Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation

George Giraud, K. L. MacCannell

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Mesenteric blood flow returned to control values promptly upon termination of i.a. infusions of vasodilator doses of acetylcholine (ACh) and isoproterenol (Iso) into the canine superior mesenteric artery (SMA). However, termination of vasodilator infusions of dopamine (DA) and epinephrine (Epi) into the SMA resulted in an additional increase in flow resembling the reactive hyperemic response observed upon termination of norepinephrine infusion into the SMA. In experiments that measured the effect of these agents on intestinal oxygen kinetics, i.a. ACh and Iso increased oxygen uptake but did not affect percent oxygen extraction. Equivasodilator i.a. infusions of DA and Epi decreased percent oxygen extraction. DA decreased oxygen uptake whereas Epi did not alter oxygen uptake. After administration of phenoxybenzamine, the effects of i.a. DA and Epi on oxygen kinetics became identical to those produced by equivasodilator infusions of ACh or Iso. Moreover, the reactive hyperemia-like response on cessation of DA and Epi infusions was abolished. In experiments that utilized 125I absorption from the jejunum as a measure of intestinal mucosal blood flow, i.a. ACh and Iso were found to increase mucosal blood flow in proportion in the increase in total SMA flow. In contrast, i.a. doses of DA and Epi that increased SMA flow nevertheless decreased mucosal flow. It was concluded that vasodilator doses of dopamine and Epi decreased oxygen delivery to the intestine at least in part due to a decreases in mucosal blood flow; this probably involves action on alpha adrenoreceptors.

Original languageEnglish (US)
Pages (from-to)214-220
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume230
Issue number1
StatePublished - 1984
Externally publishedYes

Fingerprint

Vasodilation
Epinephrine
Dopamine
Superior Mesenteric Artery
Oxygen
Food
Isoproterenol
Acetylcholine
Vasodilator Agents
Phenoxybenzamine
Hyperemia
Jejunum
Intestines
Canidae
Norepinephrine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. / Giraud, George; MacCannell, K. L.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 230, No. 1, 1984, p. 214-220.

Research output: Contribution to journalArticle

@article{9ff1962210e54ebd860c57bb24ceff27,
title = "Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation",
abstract = "Mesenteric blood flow returned to control values promptly upon termination of i.a. infusions of vasodilator doses of acetylcholine (ACh) and isoproterenol (Iso) into the canine superior mesenteric artery (SMA). However, termination of vasodilator infusions of dopamine (DA) and epinephrine (Epi) into the SMA resulted in an additional increase in flow resembling the reactive hyperemic response observed upon termination of norepinephrine infusion into the SMA. In experiments that measured the effect of these agents on intestinal oxygen kinetics, i.a. ACh and Iso increased oxygen uptake but did not affect percent oxygen extraction. Equivasodilator i.a. infusions of DA and Epi decreased percent oxygen extraction. DA decreased oxygen uptake whereas Epi did not alter oxygen uptake. After administration of phenoxybenzamine, the effects of i.a. DA and Epi on oxygen kinetics became identical to those produced by equivasodilator infusions of ACh or Iso. Moreover, the reactive hyperemia-like response on cessation of DA and Epi infusions was abolished. In experiments that utilized 125I absorption from the jejunum as a measure of intestinal mucosal blood flow, i.a. ACh and Iso were found to increase mucosal blood flow in proportion in the increase in total SMA flow. In contrast, i.a. doses of DA and Epi that increased SMA flow nevertheless decreased mucosal flow. It was concluded that vasodilator doses of dopamine and Epi decreased oxygen delivery to the intestine at least in part due to a decreases in mucosal blood flow; this probably involves action on alpha adrenoreceptors.",
author = "George Giraud and MacCannell, {K. L.}",
year = "1984",
language = "English (US)",
volume = "230",
pages = "214--220",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation

AU - Giraud, George

AU - MacCannell, K. L.

PY - 1984

Y1 - 1984

N2 - Mesenteric blood flow returned to control values promptly upon termination of i.a. infusions of vasodilator doses of acetylcholine (ACh) and isoproterenol (Iso) into the canine superior mesenteric artery (SMA). However, termination of vasodilator infusions of dopamine (DA) and epinephrine (Epi) into the SMA resulted in an additional increase in flow resembling the reactive hyperemic response observed upon termination of norepinephrine infusion into the SMA. In experiments that measured the effect of these agents on intestinal oxygen kinetics, i.a. ACh and Iso increased oxygen uptake but did not affect percent oxygen extraction. Equivasodilator i.a. infusions of DA and Epi decreased percent oxygen extraction. DA decreased oxygen uptake whereas Epi did not alter oxygen uptake. After administration of phenoxybenzamine, the effects of i.a. DA and Epi on oxygen kinetics became identical to those produced by equivasodilator infusions of ACh or Iso. Moreover, the reactive hyperemia-like response on cessation of DA and Epi infusions was abolished. In experiments that utilized 125I absorption from the jejunum as a measure of intestinal mucosal blood flow, i.a. ACh and Iso were found to increase mucosal blood flow in proportion in the increase in total SMA flow. In contrast, i.a. doses of DA and Epi that increased SMA flow nevertheless decreased mucosal flow. It was concluded that vasodilator doses of dopamine and Epi decreased oxygen delivery to the intestine at least in part due to a decreases in mucosal blood flow; this probably involves action on alpha adrenoreceptors.

AB - Mesenteric blood flow returned to control values promptly upon termination of i.a. infusions of vasodilator doses of acetylcholine (ACh) and isoproterenol (Iso) into the canine superior mesenteric artery (SMA). However, termination of vasodilator infusions of dopamine (DA) and epinephrine (Epi) into the SMA resulted in an additional increase in flow resembling the reactive hyperemic response observed upon termination of norepinephrine infusion into the SMA. In experiments that measured the effect of these agents on intestinal oxygen kinetics, i.a. ACh and Iso increased oxygen uptake but did not affect percent oxygen extraction. Equivasodilator i.a. infusions of DA and Epi decreased percent oxygen extraction. DA decreased oxygen uptake whereas Epi did not alter oxygen uptake. After administration of phenoxybenzamine, the effects of i.a. DA and Epi on oxygen kinetics became identical to those produced by equivasodilator infusions of ACh or Iso. Moreover, the reactive hyperemia-like response on cessation of DA and Epi infusions was abolished. In experiments that utilized 125I absorption from the jejunum as a measure of intestinal mucosal blood flow, i.a. ACh and Iso were found to increase mucosal blood flow in proportion in the increase in total SMA flow. In contrast, i.a. doses of DA and Epi that increased SMA flow nevertheless decreased mucosal flow. It was concluded that vasodilator doses of dopamine and Epi decreased oxygen delivery to the intestine at least in part due to a decreases in mucosal blood flow; this probably involves action on alpha adrenoreceptors.

UR - http://www.scopus.com/inward/record.url?scp=0021153957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021153957&partnerID=8YFLogxK

M3 - Article

VL - 230

SP - 214

EP - 220

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -